MedPath

Intra-Articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-Blind Randomized Study

Phase 3
Completed
Conditions
Rheumatoid Arthritis
Interventions
Procedure: intra-articular injection of etanercept
Procedure: intra-articular injection of steroid
Registration Number
NCT00522184
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

Intra-articular injection of etanercept in patient suffering from rheumatoid arthritis: a double-blind randomized study for evaluation of efficacy and safety of etanercept versus intra-articular steroid injection in acute synovitis (knee,wrist,ankle,elbow)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • must be able to understand the information about the study
  • diagnosis of rheumatoid arthritis for 6 month at least
  • suffering for 2 weeks at least
  • with evaluation of pain over 4/10
  • with stable DMARDs treatment for three month at least
Exclusion Criteria
  • infection or surgery on the target joint
  • treated with infliximab,adalimumab or anakinra

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1intra-articular injection of etanerceptpatient receiving etanercept intra-articular injection
2intra-articular injection of steroidpatient receiving steroid intra-articular injection
Primary Outcome Measures
NameTimeMethod
Painevery month during six month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rheumatology department, Hopital Archet I

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath